Literature DB >> 19458011

Upstream regulatory region alterations found in human papillomavirus type 16 (HPV-16) isolates from cervical carcinomas increase transcription, ori function, and HPV immortalization capacity in culture.

Michael J Lace1, Christina Isacson, James R Anson, Attila T Lörincz, Sharon P Wilczynski, Thomas H Haugen, Lubomír P Turek.   

Abstract

Human papillomavirus (HPV) DNAs isolated from cervical and head and neck carcinomas frequently contain nucleotide sequence alterations in the viral upstream regulatory region (URR). Our study has addressed the role such sequence changes may play in the efficiency of establishing HPV persistence and altered keratinocyte growth. Genomic mapping of integrated HPV type 16 (HPV-16) genomes from 32 cervical cancers revealed that the viral E6 and E7 oncogenes, as well as the L1 region/URR, were intact in all of them. The URR sequences from integrated and unintegrated viral DNA were found to harbor distinct sets of nucleotide substitutions. A subset of the altered URRs increased the potential of HPV-16 to establish persistent, cell growth-altering viral-genome replication in the cell. This aggressive phenotype in culture was not solely due to increased viral early gene transcription, but also to augmented initial amplification of the viral genome. As revealed in a novel ori-dependent HPV-16 plasmid amplification assay, the altered motifs that led to increased viral transcription from the intact genome also greatly augmented HPV-16 ori function. The nucleotide sequence changes correlate with those previously described in the distinct geographical North American type 1 and Asian-American variants that are associated with more aggressive disease in epidemiologic studies and encompass, but are not limited to, alterations in previously characterized sites for the negative regulatory protein YY1. Our results thus provide evidence that nucleotide alterations in HPV regulatory sequences could serve as potential prognostic markers of HPV-associated carcinogenesis.

Entities:  

Mesh:

Year:  2009        PMID: 19458011      PMCID: PMC2708609          DOI: 10.1128/JVI.00285-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  New HPV-16 European and non-European variants in Central Brazil.

Authors:  Tainá Raiol Alencar; Daniela Marreco Cerqueira; Márcio Rojas da Cruz; Patrícia Soares Wyant; Eduardo Dias Ramalho; Cláudia Renata Fernandes Martins
Journal:  Virus Genes       Date:  2006-10-18       Impact factor: 2.332

2.  Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18.

Authors:  Long Fu Xi; Laura A Koutsky; Allan Hildesheim; Denise A Galloway; Cosette M Wheeler; Rachel L Winer; Jesse Ho; Nancy B Kiviat
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-01       Impact factor: 4.254

3.  Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts.

Authors:  N Häfner; C Driesch; M Gajda; L Jansen; R Kirchmayr; I B Runnebaum; M Dürst
Journal:  Oncogene       Date:  2007-09-10       Impact factor: 9.867

4.  Clustal W and Clustal X version 2.0.

Authors:  M A Larkin; G Blackshields; N P Brown; R Chenna; P A McGettigan; H McWilliam; F Valentin; I M Wallace; A Wilm; R Lopez; J D Thompson; T J Gibson; D G Higgins
Journal:  Bioinformatics       Date:  2007-09-10       Impact factor: 6.937

5.  Human papillomavirus genotypes and HPV16 variants in penile carcinoma.

Authors:  Maria Lina Tornesello; Maria Luisa Duraturo; Simona Losito; Gerardo Botti; Silvana Pilotti; Bernardina Stefanon; Giuseppe De Palo; Antonio Gallo; Luigi Buonaguro; Franco M Buonaguro
Journal:  Int J Cancer       Date:  2008-01-01       Impact factor: 7.396

Review 6.  Human papillomavirus in cervical and head-and-neck cancer.

Authors:  Amanda Psyrri; Daniel DiMaio
Journal:  Nat Clin Pract Oncol       Date:  2008-01

7.  Activities of human papillomavirus 16 E6 natural variants in human keratinocytes.

Authors:  Yulia Asadurian; Helena Kurilin; Hava Lichtig; Anna Jackman; Pinhas Gonen; Massimo Tommasino; Ingeborg Zehbe; Levana Sherman
Journal:  J Med Virol       Date:  2007-11       Impact factor: 2.327

8.  Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India.

Authors:  Shailja Pande; Neeraj Jain; Bhupesh K Prusty; Suresh Bhambhani; Sanjay Gupta; Rajyashri Sharma; Swaraj Batra; Bhudev C Das
Journal:  J Clin Microbiol       Date:  2008-01-16       Impact factor: 5.948

9.  Molecular variants of human papillomavirus type 16 and 18 and risk for cervical neoplasia in Portugal.

Authors:  Angela Pista; Ana Oliveira; Andreia Barateiro; Helena Costa; Nuno Verdasca; Maria Teresa Paixão
Journal:  J Med Virol       Date:  2007-12       Impact factor: 2.327

10.  Overexpression of VEGF and TGF-beta1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis and HPV infection.

Authors:  Stavroula Baritaki; Stavros Sifakis; Sara Huerta-Yepez; Ioannis K Neonakis; Giannoula Soufla; Benjamin Bonavida; Demetrios A Spandidos
Journal:  Int J Oncol       Date:  2007-07       Impact factor: 5.650

View more
  20 in total

1.  In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis.

Authors:  Elizabeth Gray; Mark R Pett; Dawn Ward; David M Winder; Margaret A Stanley; Ian Roberts; Cinzia G Scarpini; Nicholas Coleman
Journal:  Cancer Res       Date:  2010-05-04       Impact factor: 12.701

2.  Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers.

Authors:  Michael J Lace; James R Anson; Jens P Klussmann; Dong Hong Wang; Elaine M Smith; Thomas H Haugen; Lubomir P Turek
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

3.  Site-directed mutagenesis of human papillomavirus 18 promoter elements and tissue-specific expression in cervical carcinoma cells.

Authors:  Mandy S Y Lung; Ning Zhang; Vincent Murray
Journal:  Virus Genes       Date:  2012-02-21       Impact factor: 2.332

4.  Cell-type specific transcriptional activities among different papillomavirus long control regions and their regulation by E2.

Authors:  Matthias Ottinger; Jennifer A Smith; Michal-Ruth Schweiger; Dana Robbins; Maria L C Powell; Jianxin You; Peter M Howley
Journal:  Virology       Date:  2009-12-20       Impact factor: 3.616

Review 5.  Regulation of human papillomavirus gene expression by splicing and polyadenylation.

Authors:  Cecilia Johansson; Stefan Schwartz
Journal:  Nat Rev Microbiol       Date:  2013-03-11       Impact factor: 60.633

6.  Human papillomavirus (HPV) type 18 induces extended growth in primary human cervical, tonsillar, or foreskin keratinocytes more effectively than other high-risk mucosal HPVs.

Authors:  Michael J Lace; James R Anson; Aloysius J Klingelhutz; John H Lee; Aaron D Bossler; Thomas H Haugen; Lubomir P Turek
Journal:  J Virol       Date:  2009-09-09       Impact factor: 5.103

7.  Genomic differences in the background of different severity in juvenile-onset respiratory papillomatoses associated with human papillomavirus type 11.

Authors:  Tamás Gáll; Andrea Kis; Tímea Zsófia Tatár; Gábor Kardos; Lajos Gergely; Krisztina Szarka
Journal:  Med Microbiol Immunol       Date:  2013-05-07       Impact factor: 3.402

8.  Photon-induced cell migration and integrin expression promoted by DNA integration of HPV16 genome.

Authors:  Stefan Rieken; Florian Simon; Daniel Habermehl; Jan Oliver Dittmar; Stephanie E Combs; Klaus Weber; Jürgen Debus; Katja Lindel
Journal:  Strahlenther Onkol       Date:  2014-03-19       Impact factor: 3.621

9.  Association of human papillomavirus type 16 long control region mutation and cervical cancer.

Authors:  Chamsai Pientong; Parichat Wongwarissara; Tipaya Ekalaksananan; Piyawut Swangphon; Pilaiwan Kleebkaow; Bunkerd Kongyingyoes; Sumalee Siriaunkgul; Kobkul Tungsinmunkong; Cheepsumon Suthipintawong
Journal:  Virol J       Date:  2013-01-23       Impact factor: 4.099

10.  Determination of the complete genome and functional analysis of HPV6 isolate VBD19/10 from a patient with aggressive recurrent respiratory papillomatosis.

Authors:  R Y Seedat; C E Combrinck; P A Bester; J-Y Lee; F J Burt
Journal:  Epidemiol Infect       Date:  2016-03-02       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.